Premium Information is available for this item - Upgrade for $1 a day
6505-01-160-6778
Usp Prazepam Capsules
6505011606778 011606778 CENTRAX CAPSULES NDC00071-0552-30
May 2023
9
Marketplace 6505-01-160-6778
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-160-6778 5+ Documents (More...)
Capsules6505011606778 011606778 CENTRAX 6505010984518 Upgrade your Account Upgrade 6505-01-098-4518Usp
Prazepam Capsules6505010984518 010984518 CENTRAX CENTRAX CAPSULES DAC 6 CENTRAX 91378 - Parke-Davis
Upgrade your Account Upgrade 6505-01-098-4518Usp Prazepam Capsules6505010984518 010984518 CENTRAX CENTRAX CAPSULES
NumberManufacturerStatusNDC00071-0553-30 91378 - Parke-Davis (Active) Original Design RNCC 3 RNVC 9 DAC 4 CENTRAX CAPSULES
DAC 6 CENTRAX 91378 - Parke-Davis (Active) Incomplete Secondary Reference RNCC 5 RNVC 1 DAC 6 CENTRAX CAPSULES
Contains 100 Tt00000000100TT NATO Stock Numbers Related to 6505-01-098-4518 6505-01-236-8908 6505-01-160-6778
Restrictions 6505-01-160-6778
6505-01-160-6778 is a Usp Prazepam Capsules that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-160-6778
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-160-6778
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-160-6778
- Part Number
- Manufacturer
- Status
- NDC00071-0552-30
- Manufacturer
- 91378 - Parke-Davis (Active)
- Original Design
- Original Design
- CENTRAX CAPSULES
- 91378 - Parke-Davis (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-160-6778
- Characteristic
- Specifications
- FIIG
- Specifications
- A510U0
- Capsule Type [AKJC]
- Any Acceptable
- Capsule Content Form [CQLS]
- Any Acceptable
- Active Medicament Medicinal Strength [AKJA]
- 5.000 Milligrams Prazepam Active Ingredient
- Primary Container Type [CQCT]
- Bottle
- Capsule Primary Container Content Quantity [CYLZ]
- 500.000
- Special Features [FEAT]
- Controlled Substance Classification:Schedule Iv
Management Data 6505-01-160-6778
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Aug 1983
- Veterans Administration (VA)
- BT
- Subscribe
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 500 Ea
- 00000000500EA
- K
NATO Stock Numbers Related to 6505-01-160-6778
Freight Information 6505-01-160-6778
6505-01-160-6778 has freight characteristics.. 6505-01-160-6778 has a variance between NMFC and UFC when transported by rail and the description should be consulted.